PTK2 and breast cancer: Results from this study are supported by a previous study demonstrating the ROS scavenging capacity of C3G in BC cells overexpressing ErbB2 and its role in blocking the ErbB2/cSrc/FAK pathway needed for cell migration and invasion [27].